Advanced search
Publication Cover
Molecular and Cellular Biology Volume 18, 1998 - Issue 6
Submit an article Journal homepage
23
Views
91
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Cloning and Characterization of a Specific Receptor for Mouse Oncostatin M

Richard A. Lindbergb Immunology, Amgen, Inc., Thousand Oaks, California91320-1789
,
Todd S.-C. Juanb Immunology, Amgen, Inc., Thousand Oaks, California91320-1789;a Departments of Pathology
,
Andrew A. Welcherb Immunology, Amgen, Inc., Thousand Oaks, California91320-1789
,
Yu Sunb Immunology, Amgen, Inc., Thousand Oaks, California91320-1789;a Departments of Pathology
,
Rod Cupplesb Immunology, Amgen, Inc., Thousand Oaks, California91320-1789
,
Brenda Guthrieb Immunology, Amgen, Inc., Thousand Oaks, California91320-1789
&
Frederick A. Fletcherb Immunology, Amgen, Inc., Thousand Oaks, California91320-1789;a Departments of PathologyCorrespondence[email protected]
 show all
Pages 3357-3367 | Received 05 Dec 1997, Accepted 02 Mar 1998, Published online: 28 Mar 2023

Citations (91)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Sare Verstockt, Bram Verstockt & Séverine Vermeire. (2019) Oncostatin M as a new diagnostic, prognostic and therapeutic target in inflammatory bowel disease (IBD). Expert Opinion on Therapeutic Targets 23:11, pages 943-954.
Read now
Lukasz Stawski & Maria Trojanowska. (2019) Oncostatin M and its role in fibrosis. Connective Tissue Research 60:1, pages 40-49.
Read now
Natalie A. Sims & Rachelle W. Johnson. (2012) Leukemia inhibitory factor: A paracrine mediator of bone metabolism. Growth Factors 30:2, pages 76-87.
Read now
Radek C. Skoda. (1999) Specificity of Signaling by Hematopoietic Cytokine Receptors: Instructive Versus Permissive Effects. Journal of Receptors and Signal Transduction 19:1-4, pages 741-772.
Read now
Sumiko Watanabe. (1998) Signal transduction of the cytokine receptor. Korean Journal of Biological Sciences 2:2, pages 153-164.
Read now

Articles from other publishers (86)

Doryssa Hermans, Evelien Houben, Paulien Baeten, Helena Slaets, Kris Janssens, Cindy Hoeks, Baharak Hosseinkhani, Gayel Duran, Seppe Bormans, Elizabeth Gowing, Chloé Hoornaert, Lien Beckers, Wing Ka Fung, Horst Schroten, Hiroshi Ishikawa, Judith Fraussen, Ronald Thoelen, Helga E. de Vries, Gijs Kooij, Stephanie Zandee, Alexandre Prat, Niels Hellings & Bieke Broux. (2022) Oncostatin M triggers brain inflammation by compromising blood–brain barrier integrity. Acta Neuropathologica 144:2, pages 259-281.
Crossref
Pedro P. C. de Souza, Petra Henning & Ulf H. Lerner. (2022) Stimulation of Osteoclast Formation by Oncostatin M and the Role of WNT16 as a Negative Feedback Regulator. International Journal of Molecular Sciences 23:6, pages 3287.
Crossref
Sarah E. Headland, Hart S. Dengler, Daqi XuGrace TengChristine Everett, Rojo A. RatsimandresyDonghong Yan, Jing Kang, Kirthana GaneshanEvgeniya V. Nazarova, Sarah GierkeChristopher J. WedelesRiccardo Guidi, Daryle J. DePianto, Katrina B. Morshead, Alison HuynhJessica MillsSean Flanagan, Shannon Hambro, Victor Nunez, Joanna E. Klementowicz, Yongchang Shi, Jianyong Wang, Jack BeversIIIIII, Vladimir Ramirez-Carrozzi, Rajita PappuAlex Abbas, Jason Vander Heiden, David F. Choy, Rajbharan Yadav, Zora ModrusanReynold A. PanettieriJr.Jr., Cynthia Koziol-White, William F. JesterJr.Jr., Brendan J. JenkinsYi CaoChristine Clarke, Cary Austin, Daniel Lafkas, Min Xu, Paul J. Wolters, Joseph R. Arron, Nathaniel R. West & Mark S. Wilson. (2022) Oncostatin M expression induced by bacterial triggers drives airway inflammatory and mucus secretion in severe asthma. Science Translational Medicine 14:627.
Crossref
Yichen Wang & Yoon-Young Jang. 2022. iPSCs - State of the Science. iPSCs - State of the Science 95 109 .
Lena Jakob, Tony Andreas Müller, Michael Rassner, Helen Kleinfelder, Pia Veratti, Jan Mitschke, Cornelius Miething, Robert A. J. Oostendorp, Dietmar Pfeifer, Miguel Waterhouse & Justus Duyster. (2021) Murine Oncostatin M Has Opposing Effects on the Proliferation of OP9 Bone Marrow Stromal Cells and NIH/3T3 Fibroblasts Signaling through the OSMR. International Journal of Molecular Sciences 22:21, pages 11649.
Crossref
Hieu-Huy Nguyen-Tran, Thi-Ngoc Nguyen, Chen-Yun Chen & Tien Hsu. (2021) Endothelial Reprogramming Stimulated by Oncostatin M Promotes Inflammation and Tumorigenesis in VHL -Deficient Kidney Tissue . Cancer Research 81:19, pages 5060-5073.
Crossref
David Sanchez-Infantes & Jacqueline M. Stephens. (2021) Adipocyte Oncostatin Receptor Regulates Adipose Tissue Homeostasis and Inflammation. Frontiers in Immunology 11.
Crossref
Takashi Toyama, Sidi Xu, Ryo Nakano, Takashi Hasegawa, Naoki Endo, Tsutomu Takahashi, Jin-Yong Lee, Akira Naganuma & Gi-Wook Hwang. (2019) The Nuclear Protein HOXB13 Enhances Methylmercury Toxicity by Inducing Oncostatin M and Promoting Its Binding to TNFR3 in Cultured Cells. Cells 9:1, pages 45.
Crossref
Evelien Houben, Niels Hellings & Bieke Broux. (2019) Oncostatin M, an Underestimated Player in the Central Nervous System. Frontiers in Immunology 10.
Crossref
Nathaniel R. West. (2019) Coordination of Immune-Stroma Crosstalk by IL-6 Family Cytokines. Frontiers in Immunology 10.
Crossref
Fernando M. Botelho, Rebecca Rodrigues, Jessica Guerette, Steven Wong, Dominik K. Fritz & Carl D. Richards. (2019) Extracellular Matrix and Fibrocyte Accumulation in BALB/c Mouse Lung upon Transient Overexpression of Oncostatin M. Cells 8:2, pages 126.
Crossref
Juan M. Adrian-Segarra, Krishnamoorthy Sreenivasan, Praveen Gajawada, Holger Lörchner, Thomas Braun & Jochen Pöling. (2018) The AB loop of oncostatin M (OSM) determines species-specific signaling in humans and mice. Journal of Biological Chemistry 293:52, pages 20181-20199.
Crossref
Nathaniel R. West, Benjamin M. J. Owens & Ahmed N. Hegazy. (2018) The oncostatin M-stromal cell axis in health and disease. Scandinavian Journal of Immunology 88:3, pages e12694.
Crossref
Stephanie M. Davis & Keith R. Pennypacker. (2018) The role of the leukemia inhibitory factor receptor in neuroprotective signaling. Pharmacology & Therapeutics 183, pages 50-57.
Crossref
Tadasuke Komori & Yoshihiro Morikawa. (2017) Oncostatin M in the development of metabolic syndrome and its potential as a novel therapeutic target. Anatomical Science International 93:2, pages 169-176.
Crossref
Zhi-Guo Zhang, Yan-Jing Chen, Li-Hua Xiang, Jing-Hua Pan, Zhen Wang, Gary Guishan Xiao & Da-Hong Ju. (2017) Protective effect of Rhizoma Dioscoreae extract against alveolar bone loss in ovariectomized rats via regulation of IL-6/STAT3 signaling. International Journal of Molecular Medicine 40:5, pages 1602-1610.
Crossref
Shamsudheen Moidunny, Marco Matos, Evelyn Wesseling, Santanu Banerjee, David J. Volsky, Rodrigo A. Cunha, Paula Agostinho, Hendrikus W. Boddeke & Sabita Roy. (2016) Oncostatin M promotes excitotoxicity by inhibiting glutamate uptake in astrocytes: implications in HIV-associated neurotoxicity. Journal of Neuroinflammation 13:1.
Crossref
Emma C. Walker, Rachelle W. Johnson, Yifang Hu, Holly J. Brennan, Ingrid J. Poulton, Jian-Guo Zhang, Brendan J. Jenkins, Gordon K. Smyth, Nicos A. Nicola & Natalie A. Sims. (2016) Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass. Journal of Biological Chemistry 291:41, pages 21703-21716.
Crossref
Masato Kanda, Toshio Nagai, Toshinao Takahashi, Mei Lan Liu, Naomichi Kondou, Atsuhiko T. Naito, Hiroshi Akazawa, Goro Sashida, Atsushi Iwama, Issei Komuro & Yoshio Kobayashi. (2016) Leukemia Inhibitory Factor Enhances Endogenous Cardiomyocyte Regeneration after Myocardial Infarction. PLOS ONE 11:5, pages e0156562.
Crossref
Heike M. Hermanns. (2015) Oncostatin M and interleukin-31: Cytokines, receptors, signal transduction and physiology. Cytokine & Growth Factor Reviews 26:5, pages 545-558.
Crossref
Kris Janssens, Anurag Maheshwari, Chris Van den Haute, Veerle Baekelandt, Piet Stinissen, Jerome J. A. Hendriks, Helena Slaets & Niels Hellings. (2015) Oncostatin M protects against demyelination by inducing a protective microglial phenotype. Glia 63:10, pages 1729-1737.
Crossref
Kris Janssens, Helena Slaets & Niels Hellings. (2015) Immunomodulatory properties of the IL-6 cytokine family in multiple sclerosis. Annals of the New York Academy of Sciences 1351:1, pages 52-60.
Crossref
Tadasuke Komori, Minoru Tanaka, Hiroto Furuta, Takashi Akamizu, Atsushi Miyajima & Yoshihiro Morikawa. (2015) Oncostatin M is a potential agent for the treatment of obesity and related metabolic disorders: a study in mice. Diabetologia 58:8, pages 1868-1876.
Crossref
Sean Lauber, Steven Wong, Jean-Claude Cutz, Minoru Tanaka, Nicole Barra, Šárka Lhoták, Ali Ashkar & Carl Douglas Richards. (2015) Novel function of Oncostatin M as a potent tumour-promoting agent in lung. International Journal of Cancer 136:4, pages 831-843.
Crossref
Carrie Elks & Jacqueline Stephens. (2015) Oncostatin M Modulation of Lipid Storage. Biology 4:1, pages 151-160.
Crossref
Benoit Le Goff, Sofie Singbrant, Brett A. Tonkin, T. John Martin, Evange Romas, Natalie A. Sims & Nicole C. Walsh. (2014) Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts. Cytokine 68:2, pages 101-109.
Crossref
Ryosuke Kobayashi, Jumpei Terakawa, Yasumasa Kato, Shafiqullah Azimi, Naoko Inoue, Yasushige Ohmori & Eiichi Hondo. (2014) The contribution of leukemia inhibitory factor (LIF) for embryo implantation differs among strains of mice. Immunobiology 219:7, pages 512-521.
Crossref
Carl D. Richards. (2013) The Enigmatic Cytokine Oncostatin M and Roles in Disease. ISRN Inflammation 2013, pages 1-23.
Crossref
Liv Brolund, Andrea Küster, Sabrina Korr, Michael Vogt & Gerhard Müller-Newen. (2011) A receptor fusion protein for the inhibition of murine oncostatin M. BMC Biotechnology 11:1.
Crossref
Paul Beatus, Dhanisha J. Jhaveri, Tara L. Walker, Peter G. Lucas, Rodney L. Rietze, Helen M. Cooper, Yoshihiro Morikawa & Perry F. Bartlett. (2011) Oncostatin M regulates neural precursor activity in the adult brain. Developmental Neurobiology 71:7, pages 619-633.
Crossref
Natalie A. Sims. (2009) gp130 signaling in bone cell biology: Multiple roles revealed by analysis of genetically altered mice. Molecular and Cellular Endocrinology 310:1-2, pages 30-39.
Crossref
F-M Huang, C-H Tsai, S-F Yang & Y-C Chang. (2009) The upregulation of oncostatin M in inflamed human dental pulps. International Endodontic Journal 42:7, pages 627-631.
Crossref
Michael H. Tomasson. (2009) Cancer stem cells: A guide for skeptics. Journal of Cellular Biochemistry 106:5, pages 745-749.
Crossref
T. S.-C. Juan, B. Bolon, R. A. Lindberg, Y. Sun, G. Van & F. A. Fletcher. (2009) Mice Overexpressing Murine Oncostatin M (OSM) Exhibit Changes in Hematopoietic and Other Organs that Are Distinct from Those of Mice Overexpressing Human OSM or Bovine OSM. Veterinary Pathology 46:1, pages 124-137.
Crossref
Paul G. Tiffen, Nader Omidvar, Nuria Marquez-Almuina, Dawn Croston, Christine J. Watson & Richard W. E. Clarkson. (2008) A Dual Role for Oncostatin M Signaling in the Differentiation and Death of Mammary Epithelial Cells in Vivo. Molecular Endocrinology 22:12, pages 2677-2688.
Crossref
Christoph Hintzen, Claude Haan, Jan P. Tuckermann, Peter C. Heinrich & Heike M. Hermanns. (2008) Oncostatin M-Induced and Constitutive Activation of the JAK2/STAT5/CIS Pathway Suppresses CCL1, but Not CCL7 and CCL8, Chemokine Expression. The Journal of Immunology 181:10, pages 7341-7349.
Crossref
Qing Zhang, Prabhakar Putheti, Qiang Zhou, Quansheng Liu & Wenda Gao. (2008) Structures and biological functions of IL-31 and IL-31 receptors. Cytokine & Growth Factor Reviews 19:5-6, pages 347-356.
Crossref
Yuichiro Miyaoka, Minoru Tanaka, Takahiro Naiki & Atsushi Miyajima. (2006) Oncostatin M Inhibits Adipogenesis through the RAS/ERK and STAT5 Signaling Pathways. Journal of Biological Chemistry 281:49, pages 37913-37920.
Crossref
Dominik K. Fritz, Christine Kerr, Li Tong, David Smyth & Carl D. Richards. (2006) Oncostatin-M Up-Regulates VCAM-1 and Synergizes with IL-4 in Eotaxin Expression: Involvement of STAT6. The Journal of Immunology 176:7, pages 4352-4360.
Crossref
Itamar Goren, Heiko Kämpfer, Elke Müller, Dana Schiefelbein, Josef Pfeilschifter & Stefan Frank. (2006) Oncostatin M Expression Is Functionally Connected to Neutrophils in the Early Inflammatory Phase of Skin Repair: Implications for Normal and Diabetes-Impaired Wounds. Journal of Investigative Dermatology 126:3, pages 628-637.
Crossref
Marie-Ève Blais, Isabelle Louis & Claude Perreault. (2006) T-cell development: an extrathymic perspective. Immunological Reviews 209:1, pages 103-114.
Crossref
Rafik TerraIsabelle LouisRichard Le BlancSophie OuelletJuan Carlos Zúñiga-PflückerClaude Perreault. (2005) T-cell generation by lymph node resident progenitor cells. Blood 106:1, pages 193-200.
Crossref
Yoshihiro Morikawa. (2005) Oncostatin M in the development of the nervous system. Anatomical Science International 80:1, pages 53-59.
Crossref
Shao-Hua Chen & Etty N. Benveniste. (2004) Oncostatin M: a pleiotropic cytokine in the central nervous system. Cytokine & Growth Factor Reviews 15:5, pages 379-391.
Crossref
George Vlotides, Kathrin Zitzmann, Gunter K. Stalla & Christoph J. Auernhammer. (2004) Novel neurotrophin-1/B cell-stimulating factor-3 (NNT-1/BSF-3) / cardiotrophin-like cytokine (CLC)—a novel gp130 cytokine with pleiotropic functions. Cytokine & Growth Factor Reviews 15:5, pages 325-336.
Crossref
Li Tong, David Smyth, Christine Kerr, Jonathon Catterall & Carl D Richards. (2004) Mitogen-activated protein kinases Erk1/2 and p38 are required for maximal regulation of TIMP-1 by oncostatin M in murine fibroblasts. Cellular Signalling 16:10, pages 1123-1132.
Crossref
M. Tanaka & A. Miyahima. 2004. Reviews of Physiology, Biochemistry and Pharmacology. Reviews of Physiology, Biochemistry and Pharmacology 39 52 .
Jean-Pierre Pelletier & Johanne Martel-Pelletier. (2003) Oncostatin M: Foe or friend?. Arthritis & Rheumatism 48:12, pages 3301-3303.
Crossref
Irene Ginis & Mahendra S Rao. (2003) Toward cell replacement therapy: promises and caveats. Experimental Neurology 184:1, pages 61-77.
Crossref
Carrie Langdon, Christine Kerr, Li Tong & Carl D. Richards. (2003) Oncostatin M Regulates Eotaxin Expression in Fibroblasts and Eosinophilic Inflammation in C57BL/6 Mice. The Journal of Immunology 170:1, pages 548-555.
Crossref
Minoru Tanaka & Atsushi Miyajima. 2003. Encyclopedia of Hormones. Encyclopedia of Hormones 61 65 .
Taisei Kinoshita & Atsushi Miyajima. (2002) Cytokine regulation of liver development. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1592:3, pages 303-312.
Crossref
Py Palmqvist, Emma Persson, H. Herschel Conaway & Ulf H. Lerner. (2002) IL-6, Leukemia Inhibitory Factor, and Oncostatin M Stimulate Bone Resorption and Regulate the Expression of Receptor Activator of NF-κB Ligand, Osteoprotegerin, and Receptor Activator of NF-κB in Mouse Calvariae. The Journal of Immunology 169:6, pages 3353-3362.
Crossref
Frédéric Blanchard, Erin Kinzie, Yanping Wang, Laurence Duplomb, Anne Godard, William A Held, Bonnie B Asch & Heinz Baumann. (2002) FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins. Oncogene 21:41, pages 6264-6277.
Crossref
Takaaki Matsui, Taisei Kinoshita, Toshio Hirano, Takashi Yokota & Atsushi Miyajima. (2002) STAT3 Down-regulates the Expression of Cyclin D during Liver Development. Journal of Biological Chemistry 277:39, pages 36167-36173.
Crossref
Alfons S.K. de Hooge, Fons A.J. van de Loo, Miranda B. Bennink, Diana S. de Jong, Onno J. Arntz, Erik Lubberts, Carl D. Richards & Wim B. van den Berg. (2002) Adenoviral Transfer of Murine Oncostatin M Elicits Periosteal Bone Apposition in Knee Joints of Mice, Despite Synovial Inflammation and Up-Regulated Expression of Interleukin-6 and Receptor Activator of Nuclear Factor-κB Ligand. The American Journal of Pathology 160:5, pages 1733-1743.
Crossref
Steven M. Kerfoot, Eko Raharjo, May Ho, Jaswinder Kaur, Supattra Serirom, Donna-Marie McCafferty, Alan R. Burns, Kamala D. Patel & Paul Kubes. (2001) Exclusive Neutrophil Recruitment with Oncostatin M in a Human System. The American Journal of Pathology 159:4, pages 1531-1539.
Crossref
Katherine A. Fitzgerald, Luke A.J. O'Neill, Andy J.H. Gearing & Robin E. Callard. 2001. The Cytokine FactsBook and Webfacts. The Cytokine FactsBook and Webfacts 415 419 .
Charles A. O'Brien, Song-Chang Lin, Teresita Bellido & Stavros C. Manolagas. (2000) Expression levels of gp130 in bone marrow stromal cells determine the magnitude of osteoclastogenic signals generated by IL-6-type cytokines. Journal of Cellular Biochemistry 79:4, pages 532-541.
Crossref
Yoshiaki Ito, Takaaki Matsui, Akihide Kamiya, Taisei Kinoshita & Atsushi Miyajima. (2000) Retroviral gene transfer of signaling molecules into murine fetal hepatocytes defines distinct roles for the STAT3 and ras pathways during hepatic development. Hepatology 32:6, pages 1370-1376.
Crossref
Ann Vernallis. 2000. Cytokine Inhibitors. Cytokine Inhibitors.
Carrie Langdon, Christine Kerr, Mohammed Hassen, Takahiko Hara, A. Larry Arsenault & Carl D. Richards. (2000) Murine Oncostatin M Stimulates Mouse Synovial Fibroblasts in Vitro and Induces Inflammation and Destruction in Mouse Joints in Vivo. The American Journal of Pathology 157:4, pages 1187-1196.
Crossref
Frédéric Blanchard, Laurence Duplomb, Yanping Wang, Olivier Robledo, Erin Kinzie, Vincent Pitard, Anne Godard, Yannick Jacques & Heinz Baumann. (2000) Stimulation of Leukemia Inhibitory Factor Receptor Degradation by Extracellular Signal-regulated Kinase. Journal of Biological Chemistry 275:37, pages 28793-28801.
Crossref
Atsushi Miyajima, Taisei Kinoshita, Minoru Tanaka, Akihide Kamiya, Yousuke Mukouyama & Takahiko Hara. (2000) Role of Oncostatin M in hematopoiesis and liver development. Cytokine & Growth Factor Reviews 11:3, pages 177-183.
Crossref
Yanping Wang, Olivier Robledo, Erin Kinzie, Frédéric Blanchard, Carl Richards, Atsushi Miyajima & Heinz Baumann. (2000) Receptor Subunit-specific Action of Oncostatin M in Hepatic Cells and Its Modulation by Leukemia Inhibitory Factor. Journal of Biological Chemistry 275:33, pages 25273-25285.
Crossref
Marc C Deller, Keith R Hudson, Shinji Ikemizu, Jerónimo Bravo, E Yvonne Jones & John K Heath. (2000) Crystal structure and functional dissection of the cytostatic cytokine oncostatin M. Structure 8:8, pages 863-874.
Crossref
C. J. Auernhammer & S. Melmed. (2000) Leukemia-Inhibitory Factor—Neuroimmune Modulator of Endocrine Function*. Endocrine Reviews 21:3, pages 313-345.
Crossref
Carl D Richards, Carrie Langdon, Paula Deschamps, Diane Pennica & Stephen G Shaughnessy. (2000) STIMULATION OF OSTEOCLAST DIFFERENTIATION IN VITRO BY MOUSE ONCOSTATIN M, LEUKAEMIA INHIBITORY FACTOR, CARDIOTROPHIN-1 AND INTERLEUKIN 6: SYNERGY WITH DEXAMETHASONE. Cytokine 12:6, pages 613-621.
Crossref
Ann M. Turnley & Perry F. Bartlett. (2000) Cytokines that Signal Through the Leukemia Inhibitory Factor Receptor-β Complex in the Nervous System. Journal of Neurochemistry 74:3, pages 889-899.
Crossref
Matthias Stanke, Markus Geissen, Rudolf Götz, Uwe Ernsberger & Hermann Rohrer. (2000) The early expression of VAChT and VIP in mouse sympathetic ganglia is not induced by cytokines acting through LIFRβ or CNTFRα. Mechanisms of Development 91:1-2, pages 91-96.
Crossref
Roger B Voyle & Peter D Rathjen. (2000) REGULATED EXPRESSION OF ALTERNATE TRANSCRIPTS FROM THE MOUSE ONCOSTATIN M GENE: IMPLICATIONS FOR INTERLEUKIN-6 FAMILY CYTOKINES. Cytokine 12:2, pages 134-141.
Crossref
Christoph J. Auernhammer & Shlomo Melmed. 2000. Principles of Molecular Regulation. Principles of Molecular Regulation 115 132 .
Longbiao YaoHendra SetiadiLijun XiaZoltan LaszikFletcher B. TaylorRodger P. McEver. (1999) Divergent Inducible Expression of P-Selectin and E-Selectin in Mice and Primates. Blood 94:11, pages 3820-3828.
Crossref
Longbiao YaoHendra SetiadiLijun XiaZoltan LaszikFletcher B. TaylorRodger P. McEver. (1999) Divergent Inducible Expression of P-Selectin and E-Selectin in Mice and Primates. Blood 94:11, pages 3820-3828.
Crossref
Christine KerrCarrie LangdonFrank GrahamJack GauldieTakahiko HaraCarl D. Richards. (1999) Adenovirus Vector Expressing Mouse Oncostatin M Induces Acute-Phase Proteins and TIMP-1 Expression In Vivo in Mice . Journal of Interferon & Cytokine Research 19:10, pages 1195-1205.
Crossref
M.J. Gómez-Lechón. (1999) Oncostatin M: Signal transduction and biological activity. Life Sciences 65:20, pages 2019-2030.
Crossref
Susan L. Grant & C.Glenn Begley. (1999) The oncostatin M signalling pathway: reversing the neoplastic phenotype?. Molecular Medicine Today 5:9, pages 406-412.
Crossref
Taisei Kinoshita, Takashi Sekiguchi, Ming-jiang Xu, Yoshiaki Ito, Akihide Kamiya, Koh-ichiro Tsuji, Tatsutoshi Nakahata & Atsushi Miyajima. (1999) Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis. Proceedings of the National Academy of Sciences 96:13, pages 7265-7270.
Crossref
Jian Zhong, Irmgard D. Dietzel, Petra Wahle, Manfred Kopf & Rolf Heumann. (1999) Sensory Impairments and Delayed Regeneration of Sensory Axons in Interleukin-6-Deficient Mice. The Journal of Neuroscience 19:11, pages 4305-4313.
Crossref
Philip M. Wallace, John F. MacMaster, Katherine A. Rouleau, T. Joseph Brown, James K. Loy, Karen L. Donaldson & Alan F. Wahl. (1999) Regulation of Inflammatory Responses by Oncostatin M. The Journal of Immunology 162:9, pages 5547-5555.
Crossref
Christopher H Clegg, Harald S Haugen, Jeffrey T Rulffes, Sherree L Friend & Andrew G Farr. (1999) Oncostatin M transforms lymphoid tissue function in transgenic mice by stimulating lymph node T-cell development and thymus autoantibody production. Experimental Hematology 27:4, pages 712-725.
Crossref
James K. Loy, Thomas J. Davidson, Karen K. Berry, John F. Macmaster, Bharat Danle & Stephen K. Durham. (2016) Oncostatin M: Development of a Pleiotropic Cytokine. Toxicologic Pathology 27:2, pages 151-155.
Crossref
Richard A. Hughes & Paul D. O'Leary. (1999) Exploiting neurotrophic factors for the treatment of neurodegenerative conditions: An Australian perspective. Drug Development Research 46:3-4, pages 268-276.
Crossref
Minoru TanakaTakahiko HaraNeal G. CopelandDebra J. GilbertNancy A. JenkinsAtsushi Miyajima. (1999) Reconstitution of the Functional Mouse Oncostatin M (OSM) Receptor: Molecular Cloning of the Mouse OSM Receptor β Subunit. Blood 93:3, pages 804-815.
Crossref
Minoru TanakaTakahiko HaraNeal G. CopelandDebra J. GilbertNancy A. JenkinsAtsushi Miyajima. (1999) Reconstitution of the Functional Mouse Oncostatin M (OSM) Receptor: Molecular Cloning of the Mouse OSM Receptor β Subunit. Blood 93:3, pages 804-815.
Crossref
Christian Schindler & Inga Strehlow. 1999. 113 174 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.